NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 195 filers reported holding NEKTAR THERAPEUTICS in Q3 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $141,000 | -28.8% | 11,500 | 0.0% | 0.01% | -31.6% |
| Q3 2016 | $198,000 | -13.2% | 11,500 | -28.1% | 0.02% | -17.4% |
| Q2 2016 | $228,000 | +3.6% | 16,000 | 0.0% | 0.02% | 0.0% |
| Q1 2016 | $220,000 | -18.5% | 16,000 | 0.0% | 0.02% | -17.9% |
| Q4 2015 | $270,000 | +45.2% | 16,000 | -5.8% | 0.03% | +40.0% |
| Q3 2015 | $186,000 | -12.3% | 16,985 | 0.0% | 0.02% | -4.8% |
| Q2 2015 | $212,000 | +13.4% | 16,985 | 0.0% | 0.02% | +10.5% |
| Q1 2015 | $187,000 | -28.9% | 16,985 | 0.0% | 0.02% | -34.5% |
| Q4 2014 | $263,000 | +25.8% | 16,985 | -1.8% | 0.03% | +16.0% |
| Q3 2014 | $209,000 | -11.8% | 17,300 | -6.5% | 0.02% | -16.7% |
| Q2 2014 | $237,000 | +12.9% | 18,500 | +6.9% | 0.03% | +7.1% |
| Q1 2014 | $210,000 | +7.1% | 17,300 | 0.0% | 0.03% | +12.0% |
| Q4 2013 | $196,000 | +4.3% | 17,300 | -3.9% | 0.02% | +4.2% |
| Q3 2013 | $188,000 | -19.7% | 18,000 | -11.3% | 0.02% | -25.0% |
| Q2 2013 | $234,000 | – | 20,300 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
| GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
| Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
| Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
| Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
| CM Management, LLC | 50,000 | $160,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
| PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
| Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
| ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |